APPLIED DNA SCIENCES INC | Business Contracts

Form of Securities Purchase Agreement, dated August 4, 2022, by and between Applied DNA Sciences, Inc. and certain purchasers (Filed With SEC on August 9, 2022)

Form of Placement Agency Agreement by and between Applied DNA Sciences, Inc. and Roth Capital Partners, LLC, dated February 21, 2022 (Filed With SEC on February 23, 2022)

Letter Agreement dated March 2, 2021, by and between the Company and Dr. James Hayward (Filed With SEC on March 4, 2021)

Agreement of Lease, dated November 1, 2015, by and between Applied DNA Sciences, Inc. and Long Island High Technology Incubator, Inc (Filed With SEC on August 6, 2020)

Consulting Agreement, dated as of December 12, 2019, by and between Applied DNA Sciences, Inc. and Meadow Hill Place, LLC (Filed With SEC on August 6, 2020)

Patent and Know-How License and Cooperation Agreement, dated March 28, 2019, between the Company, APDN (B.V.I.), Inc., and ETCH BioTrace S.A (Filed With SEC on May 9, 2019)

Form of Prefunded Warrant (Filed With SEC on August 9, 2022)

Form of Series B Warrant (Filed With SEC on August 9, 2022)

Form of Series A Warrant (Filed With SEC on August 9, 2022)

Form of Securities Purchase Agreement (Filed With SEC on August 1, 2022)

Form of Pre-Funded Warrant (Filed With SEC on August 1, 2022)

Form of Series B Warrant (Filed With SEC on August 1, 2022)

Form of Series A Warrant (Filed With SEC on August 1, 2022)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)

Form of Securities Purchase Agreement (Filed With SEC on February 23, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on February 23, 2022)

Form of Securities Purchase Agreement (Filed With SEC on January 11, 2021)

Form of Placement Agency Agreement by and between Applied DNA Sciences, Inc. and Roth Capital Partners, LLC, dated January 10, 2021 (Filed With SEC on January 11, 2021)

Animal Clinical Trial Agreement, dated September 14, 2020, between Applied DNA Sciences, Inc., Evvivax S.R.L. and Veterinary Oncology Services, PLLC (Filed With SEC on December 17, 2020)

Joint Development Agreement, dated September 11, 2018, between LineaRx, Inc., Takis S.R.L. and Evvivax S.R.L., as amended by that First Amendment, dated February 3, 2020 (Filed With SEC on December 17, 2020)

Description of Securities (Filed With SEC on December 17, 2020)

Consent, dated October 9, 2020, from Dillon Hill Capital, LLC to Applied DNA Sciences, Inc (Filed With SEC on October 14, 2020)

Letter Agreement, dated October 9, 2020, by and among Applied DNA Sciences, Inc., Dillon Hill Capital, LLC, and Delaware Trust Company, as Collateral Agent (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on October 14, 2020)

Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Investment Company LLC (Filed With SEC on October 14, 2020)

Warrant Exercise Agreement, dated October 7, 2020, by and between Applied DNA Sciences, Inc. and Dillon Hill Capital, LLC (Filed With SEC on October 14, 2020)

Amendment to Leases, dated January 17, 2020, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on August 6, 2020)

Amendment to Leases, dated November 4, 2019, by and between Long Island High Technology Incubator, Inc. and Applied DNA Sciences, Inc (Filed With SEC on August 6, 2020)

Temporary Lease Extension Agreement, dated August 9, 2019, by and between Applied DNA Sciences, Inc. and Long Island High Technology Incubator, Inc (Filed With SEC on August 6, 2020)

Description of Securities (Filed With SEC on May 14, 2020)

Warrant Agreement, dated November 15, 2019, between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 18, 2019)

Underwriting Agreement entered into by and between Applied DNA Sciences, Inc. and Maxim Group LLC, as Representative of the Underwriters listed in Schedule I hereto, dated... (Filed With SEC on November 14, 2019)

Form of pre-funded warrant (Filed With SEC on November 14, 2019)

Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on November 14, 2019)

Form of Underwriting Agreement (Filed With SEC on November 8, 2019)

Form of Underwriting Agreement (Filed With SEC on November 1, 2019)

Form of warrant agreement between Applied DNA Sciences, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on October 25, 2019)

Form of Underwriting Agreement (Filed With SEC on October 25, 2019)

Form of pre-funded warrant (Filed With SEC on October 25, 2019)

Form of Subscription Agreement between investors and Applied DNA Sciences, Inc., dated August 22, 2019 (Filed With SEC on August 26, 2019)

Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by APDN (B.V.I.) Inc. in favor of Delaware Trust Company as collateral agent for the secured... (Filed With SEC on August 13, 2019)

Second Amendment to Intellectual Property Security Agreement, dated July 19, 2019 by the Company in favor of Delaware Trust Company as collateral agent for the secured parties... (Filed With SEC on August 13, 2019)

Second Omnibus Amendment Agreement, dated July 19, 2019 by and among the Company, APDN (B.V.I.) Inc., and Delaware Trust Company, as collateral agent for the benefit of the buyers... (Filed With SEC on August 13, 2019)

Asset Purchase Agreement, dated July 29, 2019 by and between LineaRX, Inc. and Vitatex Inc (Filed With SEC on August 12, 2019)

Omnibus Amendment Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the parties named on the signature page thereof (Filed With SEC on July 17, 2019)

Amendment to Secured Convertible Notes, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investors named on the signature page thereof (Filed With SEC on July 17, 2019)

Securities Purchase Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)

Registration Rights Agreement, dated July 16, 2019 by and among Applied DNA Sciences, Inc. and the investor named on the signature page thereof (Filed With SEC on July 17, 2019)

Form of Secured Convertible Note (Filed With SEC on July 17, 2019)

First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between APDN (B.V.I.) Inc. and Delaware Trust Company as collateral agent for the benefit of... (Filed With SEC on May 9, 2019)

First Amendment to Intellectual Property Security Agreement, dated February 26, 2019, between the Company and Delaware Trust Company as collateral agent for the benefit of the... (Filed With SEC on May 9, 2019)

Omnibus Amendment Agreement, dated February 26, 2019, among the Company, APDN (B.V.I.), Inc., and Delaware Trust Company as collateral agent for the benefit of the buyers listed... (Filed With SEC on May 9, 2019)

APPLIED DNA SCIENCES INC (54)